WonderBiotics vs Provitalize: Which Wins for Menopause?

WonderBiotics vs Provitalize: Which Is Better for Menopause Weight Gain and Bloating?

Both are multi-strain probiotics built around one well-studied strain plus supporting ingredients, not a trial-tested finished capsule. WonderBiotics' Weight Management formula centers on B420 plus a metabolic blend for weight and GLP-1 support; Provitalize centers on L. gasseri SBT2055 plus turmeric for a wider band of menopause symptoms, including hot flashes. Neither has bloating-specific trial data.

During the menopause transition, visceral fat accumulation accelerates sharply starting about two years before a woman's final period, then keeps climbing afterward at a slightly slower pace rather than leveling off¹. Gut motility and hormone levels also shift during this window, though the research on that overlap is thinner than the visceral-fat data. So it's not unusual for a woman dealing with a thickening waistline to also notice more bloating and gas at the same time, and to want one product that addresses both.

How the Two Formulas Compare

Neither product shares a single probiotic strain with the other. Here's what's actually in each capsule, based on our own WonderBiotics product page² and Provitalize's product and ingredient pages^{3, 4}.

Neither company prints the individual CFU dose of its headline strain in plain text on its own product page. The retailer label listing for Provitalize gives only the 68.2 billion combined total for its three-strain blend, with no per-strain breakdown⁵. WonderBiotics doesn't disclose B420's individual CFU either. That's a transparency gap on both sides, not just one.

What the Headline-Strain Trials Show (and Don't)

Neither brand ran a clinical trial on its actual finished capsule. Both are borrowing evidence from a published trial of the strain itself, delivered in a different format than the finished capsule, at a dose that can't be confirmed against either product's current label since neither brand discloses its per-strain CFU. That distinction shapes what each product can realistically deliver.

B420 comes from a 2016 industry-funded trial of 225 overweight adults randomized to placebo, fiber, B420 alone, or B420 plus fiber, with B420 delivered as a powder stirred into a daily smoothie⁶. The predefined primary outcome (relative change in DXA-measured body fat over six months) showed no significant difference across the four groups (ANCOVA P=0.46 in the 199-person analysis set). Two secondary numbers get quoted far more often than that primary result, and each needs its own caveat. A roughly 2.4 cm (0.94 in) greater drop in waist circumference showed up in an unblinded, after-the-fact analysis that pooled the two B420-containing arms against the two without it, run on a 134-person per-protocol subset (P=0.004). That comparison wasn't the trial's own two-arm B420-vs-placebo analysis, and it wasn't a pre-registered result. Separately, a self-reported 5-day food-diary sub-analysis found the smaller B420-alone group (22 people) cut intake by about 320 kcal/day from baseline, versus a 23 kcal/day drop in the placebo group, a between-group difference of roughly 300 kcal/day (P<0.05); that's a different, smaller slice of the trial than the waist-circumference finding, and it relies on self-reported diaries rather than an objective measure of eating or hunger. Across the full trial, about 80% of the 209 people analyzed were women, averaging 49 years old, so the population skews toward the perimenopausal age range even though menopause status itself was never measured. The study was funded by DuPont Nutrition & Health, the company that owned the B420 brand at the time (now part of IFF), and every author was compensated by DuPont for their work on it.

L. gasseri SBT2055 has a cleaner design on this specific point. A 2013 trial of 210 healthy Japanese adults (105 men, 105 women, aged 35–60) with elevated visceral fat tested two doses, produced at measured concentrations of roughly 1.38 billion and 15.8 billion CFU/day rather than the nominal 200 million and 2 billion CFU/day targets, delivered in 200 g of fermented milk, against a true placebo arm, with visceral fat area as the pre-specified primary outcome⁷. Both dose groups shrank by about 8% from their own baseline (−8.5%, P<0.01, and −8.2%, P<0.01) with no dose-response relationship, while the placebo group didn't move; the difference between active and placebo groups was significant at P<0.05⁷. That 8% figure is each dose group's own before-and-after change, not a group directly compared against placebo on a percentage basis. Visceral fat area itself wasn't rescanned after the 12-week intervention, but BMI, waist and hip circumference, and body composition were re-checked four weeks later and had moved back toward baseline. Subcutaneous fat didn't improve during the trial either. (An earlier, smaller 2010 trial from the same research group had found a subcutaneous-fat effect, but this larger 2013 trial did not repeat that finding.) The paper doesn't report menopause status, so it's not possible to say what share of the 105 women were near menopause. Several of the trial's authors were employed by Megmilk Snow Brand, the maker of the SBT2055 fermented milk used in the study; the paper states it received no specific grant funding and discloses no conflict of interest.

Both brands anchor to a strain that has cleared an actual human RCT, which already puts them ahead of the many menopause probiotics that lean on animal or petri-dish data alone. Provitalize's SBT2055 trial has the cleaner primary-outcome-vs-placebo structure of the two; WonderBiotics' most quotable waist and calorie numbers come from secondary and post-hoc analyses that the original researchers ran after unblinding, not from the trial's own headline comparison.

Does Either Product Have Evidence for Bloating Specifically?

Not really, though bloating is half of what brought you here. A 2024 systematic review pooled 23 randomized trials of probiotics in adults diagnosed with irritable bowel syndrome (a diagnosed GI condition, not a general menopause population) and found that bloating scores dropped by an average of 2.13 points across 17 of those trials (5,044 observations, P=0.02)⁸. That figure describes how scores moved from before to after treatment across the pooled treatment groups; it isn't a clean head-to-head against placebo for bloating specifically, and heterogeneity between trials was extremely high (I²=99.7%)⁸. None of the 23 trials tested B420, L. gasseri SBT2055, B. breve IDCC4401, or B. lactis R101-8. So probiotics as a category have some IBS-specific signal on bloating, but neither company has bloating listed as a tested outcome for its own formula, in menopausal women or anyone else.

Which Symptoms Does Each One Target?

This is where the two products diverge the most in ambition. Our Weight Management product page keeps its claims narrow: waistline and belly fat, gut comfort alongside a GLP-1 routine, and metabolic support from dihydroberberine and Eriomin². It doesn't make claims about hot flashes, night sweats, or joint pain.

Provitalize's marketing casts a wider net, citing support for hot flashes, night sweats, joint soreness, mood swings, and energy in addition to weight and bloating³. The rationale leans on turmeric's general anti-inflammatory reputation and an internal customer survey (the company cites 94.4% of respondents reporting positive results after at least three months, though it hasn't published the survey methodology or a consistent sample size across its own materials)³, not a hot-flash-specific trial of the finished capsule. Both brands also use a similar "support your own GLP-1" framing (WonderBiotics via Eriomin², Provitalize via a GLP-1-focused marketing page for its probiotic-and-botanical blend⁹), and in both cases that's a mechanistic story built on separate small studies of the individual ingredients, not a test of the branded product itself.

If a broad menopause symptom checklist beyond the scale is your main draw, Provitalize is positioned for that. If your primary complaint is the waistline and you want a formula built around a larger, more diverse probiotic and prebiotic base plus GLP-1-adjacent actives, WonderBiotics Probiotics for Weight Management is the more focused tool.

Price, Guarantee, and Label Transparency

On a subscription basis, WonderBiotics is the cheaper option, running from $47.09/month down to $41.55/month on its longest term². On a one-time-purchase basis, though, Provitalize's single-bottle price of about $53 is slightly lower than WonderBiotics' $55.40, even though Provitalize's larger multi-bottle bundles run up to $254 total and its own site quotes roughly $1.63 per serving³. Provitalize's 90-day refund window is longer than WonderBiotics' 30 days, and it's calibrated to the company's own observation that most customers see their best results by day 90³. That guarantee only covers one-time purchases, though, not subscriptions, while WonderBiotics' 30-day guarantee covers a customer's first order (one-time or the first subscription shipment), not later subscription orders². Neither brand publishes a certificate of analysis or third-party purity test result directly on its product page, so on lab-verification transparency, it's a wash.

Who Should Choose Which

Choose our own WonderBiotics Probiotics for Weight Management if weight and waistline are your main concern, you want a broader 8-strain and prebiotic base alongside a metabolic-support blend, you're already using or considering a GLP-1 medication and want a gut-focused companion product, and you'd rather pay less per month.

Choose Provitalize if you're dealing with the fuller menopause picture — hot flashes and joint aches alongside the weight and bloating — and you'd rather have one product attempt all of it, you don't mind paying more for that breadth, and you want a longer 90-day window to judge results before committing further.

If bloating alone, without much weight change, is your main complaint, treat either product as a secondary bet rather than the main plan, since neither has bloating-specific trial data on its exact formula.

When to See a Doctor First

Probiotics are a supporting tool, not a treatment for a medical condition, and new or persistent bloating in midlife deserves a look from a clinician rather than a supplement alone. The American Cancer Society notes that bloating, pelvic or abdominal pain, feeling full quickly, and urinary urgency or frequency can also be symptoms of ovarian cancer; when these happen more than 12 times a month and represent a change from your normal pattern, it's worth seeing a doctor to rule out other causes before assuming it's hormonal¹⁰. Separately, if you're immunocompromised, on chemotherapy, have a central venous catheter, or are otherwise seriously ill, talk to your doctor before starting any probiotic, since rare bloodstream infections have been reported in that population¹¹. If you're on a GLP-1 medication or any prescription drug, check with your prescriber before adding either supplement, and don't use a probiotic as a reason to change or stop a prescribed medication on your own.

Bottom Line

Neither WonderBiotics nor Provitalize has run a trial on the exact capsule you'd buy, and neither has bloating-specific data for its own formula. What separates them is where each one focuses: Provitalize covers more of the menopause symptom list, backed by a cleaner primary-outcome trial for its lead strain. Our own product, WonderBiotics Probiotics for Weight Management, concentrates on one lane, pairing eight probiotic strains and a prebiotic with a metabolic-support blend built for the waistline and a GLP-1-era routine, at a lower monthly price. If your goal is squarely weight and gut comfort rather than the full menopause symptom list, that focus is the more direct fit.

References

1. Samargandy S, Matthews KA, Brooks MM, et al. Abdominal Visceral Adipose Tissue Over the Menopause Transition and Carotid Atherosclerosis: The SWAN Heart Study. Menopause. 2021;28(6):626-633. PMID 33651741 | PMC8141004
2. WonderBiotics Probiotics for Weight Management
3. Provitalize product page, BB Company
4. Provitalize Ingredients List, BB Company
5. Better Body Co. Provitalize ingredient/label listing, foodisgood.com
6. Stenman LK, Lehtinen MJ, Meland N, et al. Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults: Randomized Controlled Trial. EBioMedicine. 2016;13:190-200. PMID 27810310 | PMC5264483
7. Kadooka Y, Sato M, Ogawa A, et al. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. Br J Nutr. 2013;110(9):1696-1703. PMID 23614897
8. Almabruk BA, Bajafar AA, Mohamed AN, et al. Efficacy of Probiotics in the Management of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Cureus. 2024;16(12):e75954. DOI: 10.7759/cureus.75954
9. Provitalize Probiotics for Improving Menopause & Gut Health | GLP-1, BB Company
10. American Cancer Society: Ovarian Cancer Signs and Symptoms
11. Doron S, Snydman DR. Risk and Safety of Probiotics. Clin Infect Dis. 2015;60(Suppl 2):S129-S134. PMID 25922398